[Determination of the Absorption and Catabolism Rate As Well As of the Full-effect and Maintenance Dosage of -methyldigoxin in Decompensated Heart Patients]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Plasma half life of beta-methyl digoxin following repetitive application in man.
Belz G, Kleeberg U Klin Wochenschr. 1975; 53(10):491-2.
PMID: 1195654 DOI: 10.1007/BF01468636.
Half-life plasma following repetitive application of beta-acetyl digoxin in man.
Belz G, Nubling H Klin Wochenschr. 1975; 53(11):543-4.
PMID: 1152346 DOI: 10.1007/BF01468761.
References
1.
Konig E, TREPEL F, Lemp A, Merguet P, Froer K
. [Venous pressure as a criterion of cardiac efficiency. 1. Comparative measurements on clinically different patient groups]. Z Kreislaufforsch. 1968; 57(2):151-65.
View
2.
Hanel J, Meiffert G
. [On analysis of the activity of a cardiac glycoside]. Med Welt. 1968; 1:54-7.
View
3.
Belz G
. [Clinical quantitative studies on cardio-active glycosides. A review with special reference to the studies on rapid fibrillation using cymarin]. Med Welt. 1969; 35:1898-902.
View
4.
AUGSBERGER A
. [Quantitative data on therapy with cardiac glycosides. II. The cumulation and damping of the effect]. Klin Wochenschr. 1954; 32(39-40):945-51.
DOI: 10.1007/BF01466987.
View
5.
Konig E, Lemp A, Albus K
. [Quantitative properties of beta-acetyldigitoxin]. Med Klin. 1968; 63(16):627-32.
View